A nationwide survey of hepatitis C services provided by drug treatment programs

Shiela M. Strauss, Gregory P. Falkin, Zdravko Vassilev, Don C. Des Jarlais, Janetta Astone

Research output: Contribution to journalArticlepeer-review


Drug treatment programs are a site of opportunity for the delivery of primary and secondary hepatitis C (HCV) prevention services to drug users, a population at great risk for contracting and transmitting the virus. Using data collected from a random nationwide sample (N = 439) of drug treatment programs in the United States, this study examines the extent to which various types of HCV services are provided to their patients. Findings indicate that the majority of drug treatment programs educate at least some of their patients about HCV, and provide some type of support for patients who are infected with the virus. Only 29 of the programs in the sample test all of their patients for HCV, however, and 99 programs test none of them. For the most part, residential treatment programs offer more HCV related services than outpatient drug-free programs.

Original languageEnglish (US)
Pages (from-to)55-62
Number of pages8
JournalJournal of Substance Abuse Treatment
Issue number2
StatePublished - 2002


  • Disease prevention
  • Drug treatment programs
  • HCV services
  • Telephone survey
  • Treatment modality

ASJC Scopus subject areas

  • Phychiatric Mental Health
  • Medicine (miscellaneous)
  • Clinical Psychology
  • Psychiatry and Mental health


Dive into the research topics of 'A nationwide survey of hepatitis C services provided by drug treatment programs'. Together they form a unique fingerprint.

Cite this